Earnshaw S, McDade CL, Black L, Kattan M. Cost-effectiveness of chemoprevention with dutasteride based on results from the REDUCE clinical trial. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009. [abstract] Value Health. 2009 Oct; 12(7):A371.
Williams VSL, Fehnel SE, Hollis KA, Hogue SL. Antidepressant-induced sexual dysfunction (ADSD) in Europe: a preliminary investigation. Poster presented at the 2004 ISPOR 9th Annual International Meeting; May 16, 2004. Arlington, VA. [abstract] Value Health. 2004 May; 7(4):361-2.
Wincze J, Fehnel SE, McLeod LD, Granger AL, Merchant S. Development and initial testing of a new patient-reported questionnaire: erection quality scale. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research Sixth Annual European Congress; November 1, 2003. Barcelona, Spain. [abstract] Value Health. 2003 Nov; 6(6):709.
Wincze JP, Fehnel SE, McLeod LD, Granger AL, Merchant S. Development and initial testing of a new patient-reported questionnaire-erection quality scale. Value Health. 2003 Jan 1;6(6):709.
Humphries SE, Talmud PJ, Hawe E, Bolla M, Day IN, Miller GJ. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet. 2001;358(9276):115-9.
Rothman KJ, Johnson ES, Sugano DS. Is flutamide effective in patients with bilateral orchiectomy? Lancet. 1999 Apr 3;353(9159):1184. doi: 10.1016/S0140-6736(05)74403-2
Walker AM, Jick H, Hunter JR, Danford A, Watkins RN, Alhadeff L, Rothman KJ. Vasectomy and non-fatal myocardial infarction. Lancet. 1981 Jan 3;1(8210):13-5.